Author details

Full Name

Vittorio Martinelli

Affiliation

ORCID

Career Start Year

1986

Papers

331

H Index

Expertise

CM4AI Collaborator

PMID	Paper Title	Journal Title	Published Year
36675783	Combining Clinical and Genetic Data to Predict Response to Fingolimod Treatment in Relapsing Remitting Multiple Sclerosis Patients: A Precision Medicine Approach.	J Pers Med	2023
37857497	COVID-19 has no impact on disease activity, progression and cognitive performance in people with multiple sclerosis: a 2-year study.		2023
37027018	Effectiveness and safety profile of cladribine in an Italian real-life cohort of relapsing-remitting multiple sclerosis patients: a monocentric longitudinal observational study.		2023
37462753	Functional connectivity modifications in monoaminergic circuits occur in fatigued MS patients treated with fampridine and amantadine.		2023
37195347	Correction to: Effectiveness and safety profile of cladribine in an Italian real-life cohort of relapsing-remitting multiple sclerosis patients: a monocentric longitudinal observational study.		2023
36870061	Aryl hydrocarbon receptor activity downstream of IL-10 signaling is required to promote regulatory functions in human dendritic cells.		2023
36624312	Neural stem cell transplantation in patients with progressive multiple sclerosis: an open-label, phase 1 study.	Nat Med	2023
37236124	HNF4Î±, SP1 and c-myc are master regulators of CNS autoimmunity.		2023
36795147	Modifiable risk factors of COVID-19 in patients with multiple sclerosis: a single-centre case-control study.		2023
36792371	Risk HLA Variants Affect the T-Cell Repertoire in Multiple Sclerosis.		2023
35000014	HSV encephalitis associated with off-label rituximab treatment of multiple sclerosis.	Neurological Sciences	2022
35759013	Early use of fingolimod is associated with better clinical outcomes in relapsing-remitting multiple sclerosis patients.	Journal of Neurology	2022
35437271	Long-term Cognitive Outcomes and Socioprofessional Attainment in People With Multiple Sclerosis With Childhood Onset.	Neurology	2022
35483915	MR T2-relaxation time as an indirect measure of brain water content and disease activity in NMOSD.	Journal of Neurology, Neurosurgery and Psychiatry	2022
35796514	Time-varying connectivity of the precuneus and its association with cognition and depressive symptoms in neuromyelitis optica: A pilot MRI study.	Multiple Sclerosis Journal	2022
34132146	Pregnancy in multiple sclerosis women with relapses in the year before conception increases the risk of long-term disability worsening.	Multiple Sclerosis Journal	2022
34406487	Asymmetric rapidly progressive idiopathic normal-pressure hydrocephalus: description of a case.	Journal of Neurology	2022
35296189	Natalizumab treatment and pregnancy in multiple sclerosis: A reappraisal of maternal and infant outcomes after 6â¿¿years.	Multiple Sclerosis Journal	2022
34618252	PCA-LBD in Gaucher disease type 1: a case description.	Neurological Sciences	2022
34716250	Performance of the 2017 and 2010 Revised McDonald Criteria in Predicting MS Diagnosis After a Clinically Isolated Syndrome: A MAGNIMS Study.	Neurology	2022
35179760	Gut-oriented interventions in patients with multiple sclerosis: fact or fiction?	European Review for Medical and Pharmacological Sciences	2022
34795677	HIV-1 Env Does Not Enable the Development of Protective Broadly Neutralizing Antibodies in an Experimental Autoimmune Encephalomyelitis Mouse Model.	Frontiers in Immunology	2021
34297265	Stress related to COVID-19 pandemic as a trigger for disease activity in multiple sclerosis: a case report.	Neurological Sciences	2021
34181235	Transcriptomic Analysis of Peripheral Monocytes upon Fingolimod Treatment in Relapsing Remitting Multiple Sclerosis Patients.	Molecular Neurobiology	2021
33852752	Cortico-subcortical functional connectivity modifications in fatigued multiple sclerosis patients treated with fampridine and amantadine.	European Journal of Neurology	2021
34273051	Chronic lymphocytic inflammation with pontine perivascular enhancement responsive to steroids (CLIPPERS) after SARS-CoV-2 pneumonia.	Neurological Sciences	2021
34216397	Spinal Fluid Myeloid Microvesicles Predict Disease Course in Multiple Sclerosis.	Ann Neurol	2021
33620087	MYD88 L265P mutation and interleukin-10 detection in cerebrospinal fluid are highly specific discriminating markers in patients with primary central nervous system lymphoma: results from a prospective study.	Br J Haematol	2021
33991750	Identification of differential DNA methylation associated with multiple sclerosis: A family-based study.	J Neuroimmunol	2021
33829250	Subclinical anterior optic pathway involvement in early multiple sclerosis and clinically isolated syndromes.	Brain	2021
33598931	Early Predictors of 9-Year Disability in Pediatric Multiple Sclerosis.	Annals of Neurology	2021
34353742	Genomic and functional evaluation of TNFSF14 in multiple sclerosis susceptibility.	Journal of Genetics and Genomics	2021
34183414	Dysregulated copper transport in multiple sclerosis may cause demyelination via astrocytes.	Proceedings of the National Academy of Sciences of the United States of America	2021
32975468	Early evidence of disease activity during fingolimod predicts medium-term inefficacy in relapsing-remitting multiple sclerosis.	Multiple Sclerosis Journal	2021
33417007	Correction to: Refractory antiâ¿¿NMDAR encephalitis successfully treated with bortezomib and associated movements disorders controlled with tramadol: a case report with literature review.	Journal of Neurology	2021
33389030	Neutrophil-to-lymphocyte ratio: a marker of neuro-inflammation in multiple sclerosis?	J Neurol	2021
34681001	An Investigation of the Role of Common and Rare Variants in a Large Italian Multiplex Family of Multiple Sclerosis Patients.	Genes (Basel)	2021
31392924	Subclinical neurodegeneration in multiple sclerosis and neuromyelitis optica spectrum disorder revealed by optical coherence tomography.	Mult Scler	2020
32415550	CSF p-tau/AÎ² ratio and brain FDG-PET may reliably detect MCI "imminent" converters to AD.	European Journal of Nuclear Medicine and Molecular Imaging	2020
31667626	Diagnosing autoimmune encephalitis in a real-world single-centre setting.	Journal of Neurology	2020
33205062	Inferring Multiple Sclerosis Stages from the Blood Transcriptome via Machine Learning.	Cell Reports Medicine	2020
32763510	Risk attitude and personality in people with multiple sclerosis facing the choice of different disease-modifying therapy scenarios.	Journal of the Neurological Sciences	2020
32535682	Refractory anti-NMDAR encephalitis successfully treated with bortezomib and associated movements disorders controlled with tramadol: a case report with literature review.	Journal of Neurology	2020
32799417	Paramagnetic Rim Lesions are Specific to Multiple Sclerosis: An International Multicenter 3T MRI Study.	Ann Neurol	2020
32720869	Spinal Cord Atrophy in Neuromyelitis Optica Spectrum Disorders Is Spatially Related to Cord Lesions and Disability.	Radiology	2020
31221001	A pharmacogenetic study implicates <i>NINJ2</i> in the response to Interferon-Î² in multiple sclerosis.	Mult Scler	2020
31345148	The CSF p-tau181/AÎ²42 Ratio Offers a Good Accuracy "In Vivo" in the Differential Diagnosis of Alzheimer's Dementia.	Curr Alzheimer Res	2019
31598329	Changes in cortical motor outputs after a motor relapse of multiple sclerosis.	Mult Scler J Exp Transl Clin	2019
31586260	Multiple sclerosis associated with pembrolizumab in a patient with non-small cell lung cancer.	Journal of Neurology	2019
30513503	Acquired haemophilia A as a secondary autoimmune disease after alemtuzumab treatment in multiple sclerosis: A case report.	Mult Scler Relat Disord	2019